Ernexa Therapeutics CEO to present at Cell & Gene Meeting on the Mesa Emerging Track
ERNA•Ernexa Therapeutics CEO Sanjeev Luther is scheduled to present an Innovation Spotlight on Oct. 6 at the 2026 Cell & Gene Meeting on the Mesa, with a focus expected on ERNA-101 and a planned 2026 IND filing.
1. Presentation details
Ernexa will present at the meeting in Mesa, Arizona, held Oct. 5-7, 2026. Luther's Innovation Spotlight is scheduled for Oct. 6 at 1:30 p.m. and is expected to focus on ERNA-101, which targets an initial clinical path in platinum-resistant ovarian cancer ahead of a planned 2026 IND filing.
